Tomocube, Inc. (KOSDAQ:475960)

Market Cap	738.76B +212.5%
Revenue (ttm)	7.23B +18.2%
Net Income	-7.93B
EPS	-614.86
Shares Out	13.38M
PE Ratio	n/a
Forward PE	484.43
Dividend	n/a
Ex-Dividend Date	n/a

Volume	713,979
Average Volume	218,344
Open	47,600
Previous Close	49,300
Day's Range	45,850 - 56,800
52-Week Range	13,490 - 63,900
Beta	n/a
RSI	65.97
Earnings Date	Mar 20, 2026

About Tomocube

Tomocube, Inc. engages in the manufacture and sale of optical devices and medical equipment. Its holotomography (HT) products include HT-X1 for live-cell imaging and analysis; and HT-2H for 3D live cell imaging. The company also offers TomoAnalysis, a 3D image visualization and analysis software. In addition, it provides accessories, such as HT-ready 96 well plates; TomoDish that is designed to accommodate both adherent and suspension cells; TomoChamber, a stage-top incubator designed for long-term live cell imaging; TomoPlate, an active vibrat...

• Industry: Laboratory Apparatus and Furniture
• Founded: 2015
• Country: South Korea
• Stock Exchange: KOSDAQ
• Ticker Symbol: 475960

Financial Performance

In 2024, Tomocube's revenue was 5.94 billion, an increase of 58.48% compared to the previous year's 3.75 billion. Losses were -8.30 billion, -64.75% less than in 2023.